Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.54 |
| ▸ | SLC28A1 | O00337 | 2/20 | 0.54 |
| ▸ | PI4KA | P42356 | 2/20 | 0.54 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.54 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.54 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.54 |
| ▸ | DPP4 | P27487 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.54 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.54 |
| ▸ | GAPDH | P04406 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.54 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.54 |
| ▸ | STAT6 | P42226 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.54 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27657118 | 1.00 | ADORA3 (0.54) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL23042807 | 1.00 | ADORA3 (0.54) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL27992710 | 1.00 | ADORA3 (0.54) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL454216 | 1.00 | ADORA3 (0.54) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL1417403 | 1.00 | ADORA3 (0.54) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL27489485 | 0.99 | ADORA3 (0.53) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL31062627 | 0.86 | ADORA3 (0.55) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL481525 | 0.86 | ADORA3 (0.55) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| SCHEMBL27541459 | 0.86 | PI4KA (0.39) | ADORA3ADORA2ASLC28A1PI4KAPI4K2B | |
| Homocysteine SCHEMBL28127837 | 0.86 | FASN (0.51) | KMT2ADOT1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104686208-A | Usage and method for detection, processing and artificial cultivation of tussah cordyceps militaris taken as traditional Chinese medicinal materials | BEIJING MAILLARD TRADITIONAL CHINESE MEDICINE DECOCTION PIECES TECHNOLOGY CO LTD | 2015-06-10 | — | — | CN | claimed |
| US-20250223620-A1 | NOVEL PROCESSES FOR THE PRODUCTION OF POLYNUCLEOTIDES INCLUDING OLIGONUCLEOTIDES | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2025-07-10 | — | — | US | disclosed |
| EP-4504932-A1 | NOVEL PROCESSES FOR THE PRODUCTION OF POLYNUCLEOTIDES INCLUDING OLIGONUCLEOTIDES | GlaxoSmithKline Intellectual Property Development Ltd (GB) | 2025-02-12 | — | — | EP | disclosed |
| CN-119013398-A | Novel method for producing polynucleotides comprising oligonucleotides | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-11976296-B2 | Means and methods for generating midbrain organoids | UNIVERSITÉ DU LUXEMBOURG (LU) | 2024-05-07 | — | — | US | disclosed |
| WO-2023194537-A1 | NOVEL PROCESSES FOR THE PRODUCTION OF POLYNUCLEOTIDES INCLUDING OLIGONUCLEOTIDES | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-10-12 | — | — | WO | disclosed |
| CN-104686208-B | A kind of artificial culturing method of toothed oak Cordyceps militaris Chinese medicine, processing, detection and application thereof | 北京美拉德中药饮片科技有限公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-106478754-A | The preparation method of 2 ' O only son's acyl adenosine cyclophosphate | 上海上药第生化药业有限公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-104686208-A | Usage and method for detection, processing and artificial cultivation of tussah cordyceps militaris taken as traditional Chinese medicinal materials | BEIJING MAILLARD TRADITIONAL CHINESE MEDICINE DECOCTION PIECES TECHNOLOGY CO LTD | 2015-06-10 | — | — | CN | disclosed |
| CN-104686208-A | Usage and method for detection, processing and artificial cultivation of tussah cordyceps militaris taken as traditional Chinese medicinal materials | BEIJING MAILLARD TRADITIONAL CHINESE MEDICINE DECOCTION PIECES TECHNOLOGY CO LTD | 2015-06-10 | — | — | CN | disclosed |
| EP-1903873-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | THE UNIVERSITY OF ROCHESTER (US) | 2008-04-02 | — | — | EP | disclosed |
| WO-2006135602-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | UNIVERSITY OF ROCHESTER (US) | 2006-12-21 | — | — | WO | disclosed |
| US-7049303-B2 | Inhibition of viruses | MEDICAL RESEARCH COUNCIL (GB) | 2006-05-23 | — | — | US | disclosed |
| US-20050043268-A1 | Inhibition of viruses | MEDICAL RESEARCH COUNCIL (GB) | 2005-02-24 | — | — | US | disclosed |
| WO-1998001459-A1 | NOVEL N-ALKOXYADENINE DERIVATIVES ACTING AS CYTOKINE INHIBITORS | NOVO NORDISK A/S (DK) | 1998-01-15 | — | — | WO | disclosed |
| WO-1997033590-A1 | A METHOD OF TREATING DISORDERS RELATED TO CYTOKINES IN MAMMALS | NOVO NORDISK A/S (DK) | 1997-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043268-A1 | Inhibition of viruses | RNASE1, HNRNPA1, RNASEH1 | ADORA3 399/4885ADORA2A 282/4885SLC28A1 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.